Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 255

1.

Comparison between treatment of "established" versus complex "off-label" coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry.

Huseynov A, Baumann S, Nef H, Riemer T, Schneider S, Pfannenbecker T, Achenbach S, Mehilli J, Münzel T, Gori T, Wöhrle J, Zahn R, Kastner J, Schmermund A, Richardt G, Hamm CW, Akin I.

Clin Res Cardiol. 2019 Jun 29. doi: 10.1007/s00392-019-01517-8. [Epub ahead of print]

PMID:
31256259
2.

Transvascular transcatheter aortic valve implantation in 2017.

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Husser O, Gülker J, Elsässer A, Hamm CW, Achenbach S, Möllmann H.

Clin Res Cardiol. 2019 Jun 24. doi: 10.1007/s00392-019-01509-8. [Epub ahead of print]

PMID:
31236692
3.

Incidence and outcome of peri-procedural transcatheter heart valve embolization and migration: the TRAVEL registry (TranscatheteR HeArt Valve EmboLization and Migration).

Kim WK, Schäfer U, Tchetche D, Nef H, Arnold M, Avanzas P, Rudolph T, Scholtz S, Barbanti M, Kempfert J, Mangieri A, Lauten A, Frerker C, Yoon SH, Holzamer A, Praz F, De Backer O, Toggweiler S, Blumenstein J, Purita P, Tarantini G, Thilo C, Wolf A, Husser O, Pellegrini C, Burgdorf C, Antolin RAH, Díaz VAJ, Liebetrau C, Schofer N, Möllmann H, Eggebrecht H, Sondergaard L, Walther T, Pilgrim T, Hilker M, Makkar R, Unbehaun A, Börgermann J, Moris C, Achenbach S, Dörr O, Brochado B, Conradi L, Hamm CW.

Eur Heart J. 2019 Jun 23. pii: ehz429. doi: 10.1093/eurheartj/ehz429. [Epub ahead of print]

PMID:
31230081
4.

Everolimus- vs. novolimus-eluting bioresorbable scaffolds in patients with acute coronary syndrome.

Nef HM, Wiebe J, Schmidt G, Möllmann H, Boeder NF, Dörr O, Bauer T, Blachutzik F, Liebetrau C, Elsässer A, Foin N, Hamm CW.

Herz. 2019 Jun 17. doi: 10.1007/s00059-019-4822-7. [Epub ahead of print]

PMID:
31209520
5.

Predictive value of preprocedural procalcitonin for short- and long-term mortality after transfemoral transcatheter aortic valve implantation.

Keranov S, Kim WK, Arsalan M, Renker M, Keller T, Bauer T, Dörr O, Nef HM, Gaede L, Möllmann H, Walther T, Hamm CW, Liebetrau C.

Heart Vessels. 2019 Jun 7. doi: 10.1007/s00380-019-01448-4. [Epub ahead of print]

PMID:
31175405
6.

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-years Results from the GABI-R Registry.

Gori T, Achenbach S, Riemer T, Mehilli J, Nef HM, Naber C, Richardt G, Wöhrle J, Zahn R, Neumann T, Kastner J, Schmermund A, Hamm C, Münzel T.

J Clin Med. 2019 May 30;8(6). pii: E767. doi: 10.3390/jcm8060767.

7.

Annular versus supra-annular sizing for TAVI in bicuspid aortic valve stenosis.

Kim WK, Renker M, Rolf A, Fischer-Rasokat U, Wiedemeyer J, Doss M, Möllmann H, Walther T, Nef H, Hamm CW, Liebetrau C.

EuroIntervention. 2019 Jun 12;15(3):e231-e238. doi: 10.4244/EIJ-D-19-00236.

8.

Incidental Finding of Strut Malapposition Is a Predictor of Late and Very Late Thrombosis in Coronary Bioresorbable Scaffolds.

Boeder NF, Weissner M, Blachutzik F, Ullrich H, Anadol R, Tröbs M, Münzel T, Hamm CW, Dijkstra J, Achenbach S, Nef HM, Gori T.

J Clin Med. 2019 Apr 27;8(5). pii: E580. doi: 10.3390/jcm8050580.

9.

Role of percutaneous edge-to-edge repair in secondary mitral regurgitation after MITRA-FR and COAPT : A comment by the section of AV-valve treatment of the Working Group of Interventional Cardiology (AGIK) of the German Society of Cardiology (DGK).

Pfister R, Hausleiter J, Boekstegers P, Möllmann H, Nef H, Rudolph V; Working Group of Interventional Cardiology of the German Society of Cardiology.

Clin Res Cardiol. 2019 Apr 8. doi: 10.1007/s00392-019-01457-3. [Epub ahead of print] No abstract available.

PMID:
30963232
10.

OCT-assessment of scaffold resorption: Analysis of strut intensity by a new resorption index for poly-l-lactic acid bioresorbable vascular scaffolds.

Blachutzik F, Achenbach S, Marwan M, Tröbs M, Boeder N, Doerr O, Weissner M, Bauer T, Nef H, Hamm C, Schlundt C.

Catheter Cardiovasc Interv. 2019 Apr 3. doi: 10.1002/ccd.28223. [Epub ahead of print]

PMID:
30945432
11.

Calcified Plaques in Patients With Acute Coronary Syndromes.

Sugiyama T, Yamamoto E, Fracassi F, Lee H, Yonetsu T, Kakuta T, Soeda T, Saito Y, Yan BP, Kurihara O, Takano M, Niccoli G, Crea F, Higuma T, Kimura S, Minami Y, Ako J, Adriaenssens T, Boeder NF, Nef HM, Fujimoto JG, Fuster V, Finn AV, Falk E, Jang IK.

JACC Cardiovasc Interv. 2019 Mar 25;12(6):531-540. doi: 10.1016/j.jcin.2018.12.013.

PMID:
30898249
12.

Effect of Plaque Composition, Morphology, and Burden on DESolve Novolimus-Eluting Bioresorbable Vascular Scaffold Expansion and Eccentricity - An Optical Coherence Tomography Analysis.

Boeder NF, Dörr O, Bauer T, Elsässer A, Möllmann H, Achenbach S, Hamm CW, Nef HM.

Cardiovasc Revasc Med. 2019 Jun;20(6):480-484. doi: 10.1016/j.carrev.2018.07.030. Epub 2018 Aug 2.

PMID:
30638889
13.

Incidence and outcome of peri-procedural cardiogenic shock: results from the international Euro Heart Survey PCI registry.

Weipert KF, Bauer T, Nef HM, Hochadel M, Weidinger F, Gitt AK, Zeymer U, Hamm CW.

Eur Heart J Acute Cardiovasc Care. 2019 Jan 8:2048872618822460. doi: 10.1177/2048872618822460. [Epub ahead of print]

PMID:
30618264
14.

Malignant anomalous origin of circumflex artery in an elite athlete.

Most AK, Bauer T, Nef H, Hamm C, Bauer P.

Clin Res Cardiol. 2019 Jun;108(6):719-721. doi: 10.1007/s00392-018-1406-0. Epub 2018 Dec 17. No abstract available.

PMID:
30560380
15.

No evidence for humoral autoimmunity against cardiomyocytes, adrenergic or muscarinic receptors in patients with Tako-Tsubo cardiomyopathy.

Juenemann M, Nef H, Möllmann H, Singh P, Troidl C, Schramm P, Kaps M, Gerriets T, Blaes F, Tschernatsch M.

Immunobiology. 2019 Mar;224(2):220-222. doi: 10.1016/j.imbio.2018.11.005. Epub 2018 Nov 15.

PMID:
30554740
16.

Evaluation of cystatin C and neutrophil gelatinase-associated lipocalin as predictors of mortality in patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Ortlieb RM, Boeder N, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Nov;41(11):1474-1479. doi: 10.1002/clc.23089. Epub 2018 Nov 16.

17.

[Cryptogenic stroke and patent foramen ovale : S2e guidelines].

Diener HC; die Deutsche Gesellschaft für Neurologie (DGN), Grau AJ; die Deutsche Schlaganfall-Gesellschaft (DSG), Baldus S; die Deutsche Gesellschaft für Kardiologie‑, Herz- und Kreislaufforschung (DGK), Ghanem A, Gröschel K, Liebetrau C, Massberg S, Möllmann H, Nef H, Sander D, Weimar C, Wöhrle J, Mattle H; die Schweizerische Neurologische Gesellschaft.

Nervenarzt. 2018 Oct;89(10):1143-1153. doi: 10.1007/s00115-018-0609-y. Review. German. No abstract available.

PMID:
30255469
18.

Effect of non-compliant balloon postdilatation on magnesium-based bioresorbable vascular scaffolds.

Blachutzik F, Achenbach S, Tröbs M, Marwan M, Weissner M, Nef H, Schlundt C.

Catheter Cardiovasc Interv. 2019 Feb 1;93(2):202-207. doi: 10.1002/ccd.27794. Epub 2018 Sep 9.

PMID:
30196573
19.

Appropriate use criteria for optical coherence tomography guidance in percutaneous coronary interventions : Recommendations of the working group of interventional cardiology of the Netherlands Society of Cardiology.

IJsselmuiden AJJ, Zwaan EM, Oemrawsingh RM, Bom MJ, Dankers FJWM, de Boer MJ, Camaro C, van Geuns RJM, Daemen J, van der Heijden DJ, Jukema JW, Kraaijeveld AO, Meuwissen M, Schölzel BE, Pundziute G, van der Harst P, van Ramshorst J, Dirksen MT, Zivelonghi C, Agostoni P, van der Heyden JAS, Wykrzykowska JJ, Scholte MJ, Nef HM, Kofflard MJM, van Royen N, Alings M, Kedhi E.

Neth Heart J. 2018 Oct;26(10):473-483. doi: 10.1007/s12471-018-1143-z. Review.

20.

Major coronary evaginations following implantation of bioresorbable vascular scaffolds - Clinical and OCT characteristics.

Blachutzik F, Achenbach S, Marwan M, Röther J, Tröbs M, Schneider R, Nef H, Weissner M, Schlundt C.

Cardiovasc Revasc Med. 2019 Jun;20(6):485-491. doi: 10.1016/j.carrev.2018.08.001. Epub 2018 Aug 4.

PMID:
30097188
21.

The SAVI-TF Registry: 1-Year Outcomes of the European Post-Market Registry Using the ACURATE neo Transcatheter Heart Valve Under Real-World Conditions in 1,000 Patients.

Kim WK, Hengstenberg C, Hilker M, Kerber S, Schäfer U, Rudolph T, Linke A, Franz N, Kuntze T, Nef H, Kappert U, Zembala MO, Toggweiler S, Walther T, Möllmann H.

JACC Cardiovasc Interv. 2018 Jul 23;11(14):1368-1374. doi: 10.1016/j.jcin.2018.03.023.

22.

Diagnostic Performance of In-Procedure Angiography-Derived Quantitative Flow Reserve Compared to Pressure-Derived Fractional Flow Reserve: The FAVOR II Europe-Japan Study.

Westra J, Andersen BK, Campo G, Matsuo H, Koltowski L, Eftekhari A, Liu T, Di Serafino L, Di Girolamo D, Escaned J, Nef H, Naber C, Barbierato M, Tu S, Neghabat O, Madsen M, Tebaldi M, Tanigaki T, Kochman J, Somi S, Esposito G, Mercone G, Mejia-Renteria H, Ronco F, Bøtker HE, Wijns W, Christiansen EH, Holm NR.

J Am Heart Assoc. 2018 Jul 6;7(14). pii: e009603. doi: 10.1161/JAHA.118.009603.

23.

Galectin-3 and ST2 as predictors of therapeutic success in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Sommer T, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Sep;41(9):1164-1169. doi: 10.1002/clc.22996. Epub 2018 Aug 20.

24.

Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.

Liebetrau C, Gaede L, Kim WK, Arsalan M, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Kriechbaum S, Huber MT, van Linden A, Berkowitsch A, Dörr O, Nef H, Hamm CW, Walther T, Möllmann H.

Int J Cardiol. 2018 Aug 15;265:40-46. doi: 10.1016/j.ijcard.2018.02.037.

PMID:
29885699
25.

International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.

Eur Heart J. 2018 Jun 7;39(22):2032-2046. doi: 10.1093/eurheartj/ehy076.

26.

International Expert Consensus Document on Takotsubo Syndrome (Part II): Diagnostic Workup, Outcome, and Management.

Ghadri JR, Wittstein IS, Prasad A, Sharkey S, Dote K, Akashi YJ, Cammann VL, Crea F, Galiuto L, Desmet W, Yoshida T, Manfredini R, Eitel I, Kosuge M, Nef HM, Deshmukh A, Lerman A, Bossone E, Citro R, Ueyama T, Corrado D, Kurisu S, Ruschitzka F, Winchester D, Lyon AR, Omerovic E, Bax JJ, Meimoun P, Tarantini G, Rihal C, Y-Hassan S, Migliore F, Horowitz JD, Shimokawa H, Lüscher TF, Templin C.

Eur Heart J. 2018 Jun 7;39(22):2047-2062. doi: 10.1093/eurheartj/ehy077.

27.

Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).

Dörr O, Walther C, Liebetrau C, Keller T, Tabert H, Boeder N, Bayer M, Bauer P, Möllmann H, Gaede L, Troidl C, Voss S, Bauer T, Hamm CW, Nef H.

Clin Cardiol. 2018 Apr;41(4):481-487. doi: 10.1002/clc.22900. Epub 2018 Apr 17.

28.

Predictors of early scaffold thrombosis: results from the multicenter prospective German-Austrian ABSORB RegIstRy.

Wöhrle J, Nef HM, Naber C, Achenbach S, Riemer T, Mehilli J, Münzel T, Schneider S, Markovic S, Seeger J, Rottbauer W, Pfannebecker T, Richardt G, Zahn R, Gori T, Kastner J, Schmermund A, Hamm CW; GABI-R Study Group.

Coron Artery Dis. 2018 Aug;29(5):389-396. doi: 10.1097/MCA.0000000000000618.

PMID:
29649071
29.

Clinical, Angiographic, and Procedural Correlates of Very Late Absorb Scaffold Thrombosis: Multistudy Registry Results.

Ellis SG, Gori T, Serruys PW, Nef H, Steffenino G, Brugaletta S, Munzel T, Feliz C, Schmidt G, Sabaté M, Onuma Y, van Geuns RJ, Gao RL, Menichelli M, Kereiakes DJ, Stone GW, Testa L, Kimura T, Abizaid A.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):638-644. doi: 10.1016/j.jcin.2017.11.042.

30.

A multicenter post-marketing evaluation of the Elixir DESolve® Novolimus-eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study.

Nef H, Wiebe J, Boeder N, Dörr O, Bauer T, Hauptmann KE, Latib A, Colombo A, Fischer D, Rudolph T, Foin N, Richardt G, Hamm C.

Catheter Cardiovasc Interv. 2018 Nov 15;92(6):1021-1027. doi: 10.1002/ccd.27550. Epub 2018 Mar 6.

PMID:
29508518
31.

Outcome of thrombus aspiration in STEMI patients: a propensity score-adjusted study.

Blumenstein J, Kriechbaum SD, Leick J, Meyer A, Kim WK, Wolter JS, Abu-Samra M, Weipert K, Bayer M, Dörr O, Walther C, Hamm CW, Nef H, Liebetrau C, Möllmann H.

J Thromb Thrombolysis. 2018 Feb;45(2):240-249. doi: 10.1007/s11239-017-1601-2.

PMID:
29274046
32.

Outcome after transvascular transcatheter aortic valve implantation in 2016.

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Nef H, Husser O, Elsässer A, Hamm CW, Möllmann H.

Eur Heart J. 2018 Feb 21;39(8):667-675. doi: 10.1093/eurheartj/ehx688.

33.

Restenosis patterns after bioresorbable vascular scaffold implantation: Angiographic substudy of the GHOST-EU registry.

Baquet M, Nef H, Gori T, Latib A, Capodanno D, Di Mario C, Sabate M, Colombo A, Tamburino C, Mehilli J.

Catheter Cardiovasc Interv. 2018 Aug 1;92(2):276-282. doi: 10.1002/ccd.27350. Epub 2017 Nov 24.

PMID:
29171715
34.

Real-world experience using the ACURATE neo prosthesis: 30-day outcomes of 1,000 patients enrolled in the SAVI TF registry.

Möllmann H, Hengstenberg C, Hilker M, Kerber S, Schäfer U, Rudolph T, Linke A, Franz N, Kuntze T, Nef H, Kappert U, Walther T, Zembala MO, Toggweiler S, Kim WK.

EuroIntervention. 2018 Feb 2;13(15):e1764-e1770. doi: 10.4244/EIJ-D-17-00628.

35.

Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.

Yamaji K, Ueki Y, Souteyrand G, Daemen J, Wiebe J, Nef H, Adriaenssens T, Loh JP, Lattuca B, Wykrzykowska JJ, Gomez-Lara J, Timmers L, Motreff P, Hoppmann P, Abdel-Wahab M, Byrne RA, Meincke F, Boeder N, Honton B, O'Sullivan CJ, Ielasi A, Delarche N, Christ G, Lee JKT, Lee M, Amabile N, Karagiannis A, Windecker S, Räber L.

J Am Coll Cardiol. 2017 Nov 7;70(19):2330-2344. doi: 10.1016/j.jacc.2017.09.014.

36.

Clinical outcomes of patients with diabetes mellitus treated with Absorb bioresorbable vascular scaffolds: a subanalysis of the European Multicentre GHOST-EU Registry.

Capranzano P, Capodanno D, Brugaletta S, Latib A, Mehilli J, Nef H, Gori T, Lesiak M, Geraci S, Pyxaras S, Mattesini A, Münzel T, Araszkiewicz A, Caramanno G, Naber C, Di Mario C, Sabatè M, Colombo A, Wiebe J, Tamburino C.

Catheter Cardiovasc Interv. 2018 Feb 15;91(3):444-453. doi: 10.1002/ccd.27388. Epub 2017 Oct 25.

PMID:
29068130
37.

[Heart valve disesases : How sufficient is the knowledge of the German population?]

Gaede L, Blumenstein J, Liebetrau C, Dörr O, Kim WK, Hamm C, Elsässer A, Nef H, Möllmann H.

Herz. 2019 Apr;44(2):161-169. doi: 10.1007/s00059-017-4632-8. Epub 2017 Oct 20. German.

PMID:
29052748
38.

Pacemaker implantation after TAVI: predictors of AV block persistence.

Gaede L, Kim WK, Liebetrau C, Dörr O, Sperzel J, Blumenstein J, Berkowitsch A, Walther T, Hamm C, Elsässer A, Nef H, Möllmann H.

Clin Res Cardiol. 2018 Jan;107(1):60-69. doi: 10.1007/s00392-017-1158-2. Epub 2017 Sep 29.

PMID:
28963581
39.

Coronary Artery Aneurysm With Thrombosis After Implantation of a Bioresorbable Coronary Artery Scaffold.

Hemetsberger R, Gürocak O, Soud M, Garcia-Garcia HM, Weber-Albers J, Nef H, Möllmann H.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):e173-e174. doi: 10.1016/j.jcin.2017.07.041. No abstract available.

40.

Clinical, Angiographic, and Procedural Correlates of Acute, Subacute, and Late Absorb Scaffold Thrombosis.

Ellis SG, Steffenino G, Kereiakes DJ, Stone GW, van Geuns RJ, Abizaid A, Nef H, Cortese B, Testa L, Menichelli M, Tamburino C, Gori T, Kimura T, Serruys PW, Brugaletta S, Sabaté M, Gao RL.

JACC Cardiovasc Interv. 2017 Sep 25;10(18):1809-1815. doi: 10.1016/j.jcin.2017.06.067.

41.

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R).

Nef HM, Wiebe J, Kastner J, Mehilli J, Muenzel T, Naber C, Neumann T, Richardt G, Schmermund A, Woehrle J, Zahn R, Riemer T, Achenbach S, Hamm CW.

EuroIntervention. 2017 Dec 20;13(11):1311-1318. doi: 10.4244/EIJ-D-17-00330.

42.

Identification of Periprocedural Myocardial Infarction Using a High-Sensitivity Troponin I Assay in Patients Who Underwent Transcatheter Aortic Valve Implantation.

Liebetrau C, Kim WK, Meyer A, Arsalan M, Gaede L, Blumenstein JM, Fischer-Rasokat U, Wolter JS, Dörr O, Schillinger S, Troidl C, Nef HM, Hamm CW, Walther T, Möllmann H.

Am J Cardiol. 2017 Oct 1;120(7):1180-1186. doi: 10.1016/j.amjcard.2017.06.069. Epub 2017 Jul 14.

PMID:
28826900
43.

Applicability and procedural success rate of bioresorbable -vascular scaffolds for percutaneous coronary intervention in an all-comer cohort of 383 consecutive patients.

Schlundt C, Achenbach S, Felten F, Roether J, Marwan M, Nef H, Ludwig J, Tröbs M.

Acta Cardiol. 2017 Aug;72(4):425-432. doi: 10.1080/00015385.2017.1307659. Epub 2017 Jul 14.

PMID:
28705057
44.

Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.

Gaede L, Liebetrau C, Dörr O, Blumenstein J, Elsässer A, Hamm CW, Möllmann H, Schlundt C, Nef HM, Achenbach S.

Coron Artery Dis. 2017 Nov;28(7):588-596. doi: 10.1097/MCA.0000000000000533.

PMID:
28704242
45.

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R.

Mehilli J, Achenbach S, Woehrle J, Baquet M, Riemer T, Muenzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C.

EuroIntervention. 2017 Dec 20;13(11):1319-1326. doi: 10.4244/EIJ-D-17-00291.

46.

Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.

Boeder NF, Dörr O, Bauer T, Mattesini A, Elsässer A, Liebetrau C, Achenbach S, Hamm CW, Nef HM.

Int J Cardiol. 2017 Nov 1;246:74-79. doi: 10.1016/j.ijcard.2017.05.087. Epub 2017 May 24.

PMID:
28579164
47.

Myocardial Ischemia Caused by Subepicardial Hematoma.

Grieshaber P, Nef H, Böning A, Niemann B.

Thorac Cardiovasc Surg Rep. 2017 Jan;6(1):e5-e9. doi: 10.1055/s-0037-1601315.

48.

Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry.

Schnorbus B, Wiebe J, Capodanno D, Brugaletta S, Geraci S, Mehilli J, Latib A, Lesiak M, Jensen C, Mattesini A, Münzel T, Capranzano P, Di Mario C, Naber C, Araszkiewicz A, Colombo A, Caramanno G, Sabate M, Tamburino C, Nef H, Gori T.

EuroIntervention. 2017 Oct 13;13(9):e1104-e1111. doi: 10.4244/EIJ-D-16-00568.

49.

Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST-EU Registry.

Geraci S, Kawamoto H, Caramanno G, Ruparelia N, Capodanno D, Brugaletta S, Gori T, Nef H, Sabate M, Mehilli J, Lesiak M, Naber C, Di Mario C, Capranzano P, Wiebe J, Araszkiewicz A, Pyxaras S, Mattesini A, Münzel T, Tamburino C, Colombo A, Latib A.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):560-568. doi: 10.1016/j.jcin.2016.12.013. Epub 2017 Mar 1.

50.

Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score.

Ortega-Paz L, Capodanno D, Gori T, Nef H, Latib A, Caramanno G, Di Mario C, Naber C, Lesiak M, Capranzano P, Wiebe J, Mehilli J, Araszkiewicz A, Pyxaras S, Mattesini A, Geraci S, Naganuma T, Colombo A, Münzel T, Sabaté M, Tamburino C, Brugaletta S.

EuroIntervention. 2017 Apr 20;12(17):2110-2117. doi: 10.4244/EIJ-D-16-00974.

PMID:
28246060

Supplemental Content

Support Center